Oncology Pharma Inc. (ONPH)
OTCMKTS · Delayed Price · Currency is USD
0.0103
+0.0003 (3.00%)
At close: Mar 4, 2026
Oncology Pharma Market Cap
Oncology Pharma has a market cap or net worth of $398.23 thousand as of March 5, 2026. Its market cap has increased by 10,200.85% in one year.
Market Cap
398.23K
Enterprise Value
n/a
Revenue
10.21K
Ranking
n/a
PE Ratio
2.14
Stock Price
$0.01
Market Cap Chart
Since April 1, 2016, Oncology Pharma's market cap has increased from 27.10K to 398.23K, an increase of 1,369.49%. That is a compound annual growth rate of 31.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 398.23K | 157.50% |
| Dec 31, 2025 | 154.65K | 3,900.34% |
| Dec 31, 2024 | 3.87K | -50.01% |
| Dec 29, 2023 | 7.73K | -99.94% |
| Dec 30, 2022 | 13.06M | -90.45% |
| Dec 31, 2021 | 136.74M | 1,159.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Apr 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Windtree Therapeutics | 642.75K |
| Bio-Path Holdings | 577.35K |
| Altamira Therapeutics | 571.55K |
| Aibotics | 512.47K |
| Hepion Pharmaceuticals | 464.81K |
| Regenerative Medical Technology Group | 394.17K |
| Actavia Life Sciences | 385.91K |
| Helix BioMedix | 382.01K |